ANI Pharma (ANIP) Tops Q2 EPS by 1c

ANI Pharma (NASDAQ: ANIP) reported Q2 EPS of $0.55, $0.01 better than the analyst estimate of $0.54. Revenue for the quarter came in at $19.52 million versus the consensus estimate of $20.3 million.

For earnings history and earnings-related data on ANI Pharma (ANIP) click here.

You May Also Be Interested In

• ANI Pharmaceuticals (ANIP) PT Lowered to $119 at Guggenheim
• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
• Lucid Diagnostics Inc. (LUCD) Reports In-Line Q2 EPS